Rodríguez-de Rivera-Campillo
E, López-López J. Evaluation of the response to
treatment and clinical evolution in patients with burning mouth syndrome. Med Oral Patol Oral Cir Bucal. 2013 May 1;18
(3):e403-10.
doi:10.4317/medoral.18142
http://dx.doi.org/doi:10.4317/medoral.18142
|
1. Minguez-Sanz
MP, Salort-LLorca C, Silvestre-Donat
FJ. Etiology
of burning mouth syndrome: A review and update. Med
Oral Patol Oral Cir Bucal. 2011;16:e144-8. |
||||
|
|
||||
|
2. Mock D, Chugh D. Burning mouth syndrome. Int J Oral Sci. 2010;2:1-4. |
||||
|
|
||||
|
3. Glazar I, Urek
MM, Brumini G, Pezelj-Ribaric
S. Oral sensorial complaints, salivary flow rate and mucosal lesions in the
institutionalized elderly. J Oral Rehabil. 2010;37:93-9. |
||||
|
|
||||
|
4. López-Jornet P, Camacho-Alonso F, Andujar-Mateos P, Sánchez-Siles
M, Gómez-García F. Burning mouth syndrome: an
update. Med Oral Patol Oral Cir
Bucal. 2010;15:562-8. |
||||
|
|
||||
|
5. Ni Riordain R, Moloney
E, O'Sullivan K, McCreary C. Burning mouth syndrome and oral health-related
quality of life: is there a change over time? Oral Dis. 2010;16:643-7. |
||||
|
|
||||
|
6. Klasser GD, Fischer DJ, Epstein JB.
Burning mouth syndrome: recognition, understanding, and management. Oral Maxillofac Surg Clin North Am. 2008;20:255-71. |
||||
|
|
||||
|
7. El-Etr M. Critical commentary 3: steroid dysregulation and stomatodynia
(burning mouth syndrome). J Orofac Pain. 2009;23:216-8. |
||||
|
|
||||
|
8. Beneyto YM, Jornet
PL, Nicolás AV, García
VJ. Letter to the Editor: Attitudes among Spanish general dentists in
relation to burning mouth syndrome: results of a national survey. Med Oral Patol Oral Cir
Bucal. 2008;13:e753-4. |
||||
|
|
||||
|
9. Soares
MS, Chimenos-Küstner E, Subirá-Pifarrè
C, Rodríguez de Rivera-Campillo ME, López-López J. Association
of Burning Mouth Syndrome with xerostomia and medicines. Med
Oral Patol Oral Cir Bucal. 2005;10:301-8. |
||||
|
|
||||
|
10. Mínguez Serra MP, Salort Llorca C, Silvestre Donat FJ. Pharmacological treatment of burning mouth syndrome:
a review and update. Med Oral Patol Oral Cir
Bucal. 2007;12:e299-304. |
||||
|
|
||||
|
11. Patton LL, Siegel MA, Benoliel R, De Laat A. Management of burning mouth syndrome: systematic
review and management recommendations. Oral Surg
Oral Med Oral Pathol Oral Radiol
Endod. 2007;103:1-13. |
||||
|
|
||||
|
12. Miziara
ID, Filho BC, Oliveira R,
Rodrigues dos Santos RM. Group psychotherapy: an
additional approach to burning mouth syndrome. J Psychosom
Res. 2009;67:443-8. |
||||
|
|
||||
|
13. Barker KE, Batstone MD, Savage NW.
Comparison of treatment modalities in burnig mouth
syndrome. Aust Dent J. 2009;54:300-5. |
||||
|
|
||||
|
14. Suh KI, Lee JY, Chung JW, Kim YK, Kho HS. Relationship between salivary flow rate and
clinical symptoms and behaviours in patients with
dry mouth. J Oral Rehabil.
2007;34:739-44. |
||||
|
|
||||
|
15. de Moura SA, de Sousa JM, Lima DF, Negreiros
AN, Silva Fde V, d Costa LJ. Burning mouth
syndrome (BMS): sialometric and sialochemical
analysis and salivary protein profile. Gerodontology. 2007;24:173-6. |
||||
|
|
||||
|
16. Beneyto YM, Jornet
PL, Nicolás AV, García
VJ. Letter to the Editor: Attitudes among Spanish general dentists in
relation to burning mouth syndrome: results of a national survey. Med Oral Patol Oral Cir
Bucal. 2008;13:753-4. |
||||
|
|
||||
|
17. Scardina GA, Carini
F, Valenza V, Messina P. Topical capsaicin
application and axon reflex vasodilatation of the tongue: neurogenic
involvement in burning mouth syndrome. Methods Find Exp Clin
Pharmacol. 2006;28:707-11. |
||||
|
|
||||
|
18. Cavalcanti
DR, da Silveira FR. Alpha lipoic acid in
burning mouth syndrome: a randomized double-bind placebo-controlled trial. J
Oral Pathol Med. 2009;38:254-61. |
||||
|
|
||||
|
19. López-D'Alessandro E, Escovich L. Combination of alpha lipoic
acid and gabapentin, its efficacy in the treatment
of Burning Mouth Syndrome: A randomized, double-blind, placebo controlled
trial. Med Oral Patol Oral Cir
Bucal. 2011;16:e635-40. |
||||
|
|
||||
|
20. Gremeau-Richard C, Woda
A, Navez ML, Attal N, Bouhassira D, Gagnieu MC, et
al. Topical clonazepam in stomatodynia:
a randomised placebo-controlled study. Pain. 2004;108:51-7. |
||||
|
|
||||
|
21. Rodriguez
de Rivera Campillo E, López López J, Chimenos Küstner E. Response to topic Clonazepam
in patients with burning mouth syndrome: a clinical study. Bull Group Int Rech Sci
Stomatol Odontol. 2010;49:19-29. |
||||
|
|
||||
|
22. Rodríguez de
Rivera-Campillo ME, López-López J, Chimenos-Küstner
E. Tratamiento del síndrome de boca ardiente con clonacepam
tópico. Piel. 2011;26:263-8. |
||||
|
|
||||
|
23. Sardella A, Lodi G, Demarosi
F, Bez C, Cassano S, Carrassi A. Burning mouth syndrome: a retrospective study
investigating spontaneous remission and response to treatments. Oral Dis. 2006;12:152-5. |
||||
|
|
||||
|
24. Jääskeläinen SK, Rinne
JO, Forssell H, Tenovuo
O, Kaasinen V, Sonninen
P, et al. Role of the dopaminergic system in
chronic pain. A fluorodopa-PET study. Pain. 2000;90:257-60. |
||||
|
|
||||
|
25. Jääskeläinen SK Forssell
H, Tenovuo O. Abnormalities of the blink reflex in
burning mouth syndrome. Pain. 1997;73:455-60. |
||||
|
|
||||
|
26. Amos K, Yeoh SC, Farah CS. Combined
topical and systemic clonazepam therapy for the
management of burning mouth syndrome: a retrospective pilot study. J Orofac Pain. 2011;25:125-30. |
||||
|
|
||||
|
27. Grushka M, Sessle
BJ. Burning mouth syndrome. Dent Clin North Am.
1991;35:171-84. |
||||
|
|
||||
|
28. Danhauer SC, Miller CS, Rhodus NL, Carlson CR. Impact of criteria-based diagnosis
of burning mouth syndrome on treatment outcome. J Orofac Pain. 2002;16:305-11. |
||||
|
|
||||